Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes

Gene Therapy volume 13, pages 1088–1096 (2006)Cite this article

Abstract

Efficient vaccination against viral agents requires a strong T-cell-mediated immune response to clear viral-infected cells. Optimal vaccination can be achieved by administration of recombinant viral vectors encoding phatogen antigens. Adenoviral vectors have attracted considerable attention as potential viral vectors for genetic vaccination owing to their favorable safety profile and potent transduction efficiency following intramuscular injection. However, the neutralizing antibody response against adenoviral capsid proteins following adenoviral vectors injection limits the success of vaccination protocols based on multiple administrations of the same adenoviral serotype. In this work, we describe efficient immunization of rhesus macaques, the preferred model for preclinical assessment, with an HCV candidate vaccine by heterologous priming–boosting with adenoviral vectors based on different serotypes. The induced responses are broad and show significant cross-strain reactivity. Boosting can be delayed for over 2 years after priming, indicating that there is long-term maintenance of resting memory cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Shiver JW, Emini AE . Recent advances in the development of HIV-1 vaccines using replication-incompentent adenovirus vectors. Annu Rev Med 2004; 55: 355–372.

    Article  CAS  Google Scholar 

  2. Prevec L, Shneider M, Rosenthal KL, Belbeck LW, Derbyshire JB, Grahm FL . Use of human adenovirus-based vectors for antigen expression in animals. J Gen Virol 1989; 70: 429–434.

    Article  CAS  Google Scholar 

  3. Prevec L, Campbell JB, Christie BS, Belbeck LW, Grahm FL . A recombinant human adenovirus vaccine against rabies. J Infect Dis 1990; 161: 27–30.

    Article  CAS  Google Scholar 

  4. Rodrigues EG, Zavala F, Eichinger D, Wilson JM, Tsuji M . Single immunization dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J Immunol 1997; 158: 1268–1274.

    CAS  PubMed  Google Scholar 

  5. Rocha CD, Caetano BC, Machado AV, Bruna-Romero O . Recombinant viruses as tools to induce protective cellular immunity against infectious diseases. Int Microbiol 2004; 7: 83–94.

    CAS  PubMed  Google Scholar 

  6. Tatsis N, Ertl HC . Adenoviruses as vaccine vectors. Mol Ther 2004; 4: 616–629.

    Article  Google Scholar 

  7. Casimiro DR, Bett AJ, Fu TM, Davies ME, Tang A, Wilson KA et al. Heterologous human immunodeficiency virus type 1 priming-boosting immunizationstrategies involving replication-defective adenovirus and poxvirus vaccine vectors. J Virol 2004; 78: 11434–11438.

    Article  CAS  Google Scholar 

  8. Capone S, Meola A, Ercole BB, Vitelli A, Pezzanera M, Ruggeri L et al. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques. J Virol 2006; 80: 1688–1699.

    Article  CAS  Google Scholar 

  9. Pinto AR, Fitzgerald JC, Giles-Davis W, Gao GP, Wilson JM, Ertl HC . Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. J Immunol 2003; 171: 6774–6779.

    Article  CAS  Google Scholar 

  10. Roy S, Gao G, Lu Y, Zhou X, Lock M, Calcedo R et al. Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors. Hum Gene Ther 2004; 5: 519–530.

    Article  Google Scholar 

  11. Kostense S, Koudstaal W, Sprangers M, Weverling GJ, Penders G, Helmus N et al. Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector. AIDS 2004; 8: 1213–1216.

    Article  Google Scholar 

  12. Vogels RD, Zuijdgeest D, van Rijnsoever R, Hartkoorn E, Damen I, de Bethune MP et al. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol 2003; 15: 8263–8271.

    Article  Google Scholar 

  13. Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S, Laidlaw SM et al. Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci USA 2005; 13: 4836–4841.

    Article  Google Scholar 

  14. Evans RK, Nawrocki DK, Isopi LA, Williams DM, Casimiro DR, Chin S et al. Development of stable liquid formulations for adenovirus-based vaccines. J Pharm Sci 2004; 93: 2458–2475.

    Article  CAS  Google Scholar 

  15. Reyes-Sandoval A, Fitzgerald JC, Grant R, Roy S, Xiang ZQ, Li Y et al. Human immunodeficiency virus type 1-specific immune response in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. J Virol 2004; 78: 7392–7399.

    Article  CAS  Google Scholar 

  16. Fallaux FJ, Bout A, van der Velde I, van den Wollenberg DJ, Hehir KM, Keegan J et al. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum Gene Ther 1998; 13: 1909–1917.

    Article  Google Scholar 

  17. Rochlitz CF . Gene therapy of cancer. Drugs Today (Barc) 2000; 9: 619–629.

    Article  Google Scholar 

  18. Rochlitz CF . Gene therapy of cancer. Swiss Med Wkly 2001; 12: 4–9.

    Google Scholar 

  19. Rose NF, Marx PA, Luckay A, Nixon DF, Moretto WJ, Donahoe SM et al. An effective AIDS vaccine based on live attenuated vescicolar stomatitis virus recombinants. Cell 2001; 106: 539–549.

    Article  CAS  Google Scholar 

  20. Folgori A, Spada E, Pezzanera M, Ruggeri L, Mele A, Garbuglia AR et al. Early impairment of HCV-specific T-cell proliferation during acute infection leads to failure of viral clearance. Gut 2006; 16: [E-pub ahead of print].

  21. Casimiro DR, Chen L, Fu TM, Evans RK, Caulfield MJ, Davies ME et al. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectros expressing a human immunodeficiency virus type 1 gag gene. J Virol 2003; 77: 6305–6313.

    Article  CAS  Google Scholar 

  22. Spada E, Mele A, Berton A, Ruggeri L, Ferrigno L, Garbuglia AR et al. Multi-specific T-cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 2004; 11: 1673–1681.

    Article  Google Scholar 

  23. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10: 439–449.

    Article  CAS  Google Scholar 

  24. Evans RK, Nawrocki DK, Isopi LA, Williams DM, Casimiro DR, Chin S et al. Development of stable liquid formulations for adenovirus-based vaccines. J Pharm Sci 2004; 93: 2458–2475.

    Article  CAS  Google Scholar 

  25. Catalucci D, Sporeno E, Cirillo A, Ciliberto G, Nicosia A, Colloca S . An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors. J Virol 2005; 79: 6400–6409.

    Article  CAS  Google Scholar 

  26. Aste-Amezaga M, Bett AJ, Wang F, Casimiro DR, Antonello JM, Patel DK et al. Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum Gene Ther 2004; 15: 293–304.

    Article  CAS  Google Scholar 

  27. Zucchelli S, Capone S, Fattori E, Folgori A, Di Marco A, Casimiro D et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000; 24: 11598–11607.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Cellular Biololgy, Istituto di Ricerche di Biologia Molecolare ‘P Angeletti’, Pomezia, Rome, Italy

    E Fattori, I Zampaglione, M Arcuri, A Meola, B B Ercole, A Cirillo, A Folgori, M Cappelletti, E Sporeno, R Cortese, A Nicosia & S Colloca

  2. Merck Research Laboratories, West Point, PA, USA

    A Bett

Authors
  1. E Fattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I Zampaglione
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Arcuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Meola
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B B Ercole
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Cirillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Folgori
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Bett
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Cappelletti
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E Sporeno
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R Cortese
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Nicosia
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. S Colloca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Fattori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fattori, E., Zampaglione, I., Arcuri, M. et al. Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming–boosting with novel adenoviral vectors based on different serotypes. Gene Ther 13, 1088–1096 (2006). https://doi.org/10.1038/sj.gt.3302754

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302754

Keywords

This article is cited by

Search

Advanced search

Quick links